Silvia Marce
Badalona, CT 08916, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response.
Journal: Journal of clinical medicine
Published: December 13, 2023
Flow cytometry to detect bone marrow involvement by follicular lymphoma.
Journal: Cytometry. Part B, Clinical cytometry
Published: June 29, 2022
Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.
Journal: Journal of clinical medicine
Published: June 15, 2021
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival.
Journal: Clinical epigenetics
Published: July 15, 2020
Coexistence of JAK2V617F mutation and isolated del(5q) in a patient with thrombocytosis.
Journal: Medicina clinica
Published: April 15, 2020
FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
Journal: Cytometry. Part B, Clinical cytometry
Published: November 29, 2019
Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms.
Journal: American journal of hematology
Published: June 19, 2019
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.
Journal: Oncotarget
Published: December 06, 2017
Highly variable mutational profile of ASXL1 in myelofibrosis.
Journal: European journal of haematology
Published: December 25, 2015
Last Updated: 09/26/2026